Andon Health Co., Ltd. (SHE:002432)
China · Delayed Price · Currency is CNY 76.13
-2.17 (-2.77%)
May 8, 2026, 3:04 PM CST
Andon Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,150 | 1,356 | 2,578 | 3,172 | 26,265 | 2,340 |
Other Revenue | 9.85 | 9.85 | 13.85 | 58.66 | 50.51 | 57.06 |
| 1,160 | 1,366 | 2,592 | 3,231 | 26,315 | 2,397 | |
Revenue Growth (YoY) | -50.36% | -47.32% | -19.77% | -87.72% | 997.80% | 19.36% |
Cost of Revenue | 467.07 | 523.38 | 784.96 | 1,275 | 5,529 | 884.82 |
Gross Profit | 693.01 | 842.21 | 1,807 | 1,956 | 20,786 | 1,512 |
Selling, General & Admin | 766.03 | 845.71 | 863.38 | 886.05 | 2,004 | 496.55 |
Research & Development | 287.8 | 323.57 | 260.69 | 278.46 | 264.89 | 66.73 |
Other Operating Expenses | -0.37 | -0.02 | 3.4 | 41.6 | 4.15 | 6.25 |
Operating Expenses | 1,048 | 1,166 | 1,130 | 1,203 | 2,286 | 592.96 |
Operating Income | -354.7 | -324.28 | 677.15 | 752.66 | 18,500 | 919.31 |
Interest Expense | -124.3 | -113.52 | -67.16 | -12.43 | -4.75 | -13.3 |
Interest & Investment Income | 810.89 | 857.48 | 800.45 | 735.36 | 274.1 | 62.35 |
Currency Exchange Gain (Loss) | 10.34 | 10.34 | -11.92 | 40.13 | 35.26 | -2.2 |
Other Non Operating Income (Expenses) | -74.32 | -4.09 | -2.26 | -2.8 | -1.98 | -3.86 |
EBT Excluding Unusual Items | 267.91 | 425.92 | 1,396 | 1,513 | 18,803 | 962.29 |
Impairment of Goodwill | - | - | - | -89.5 | -125.26 | - |
Gain (Loss) on Sale of Investments | 2,358 | 2,114 | 735.6 | 309.29 | -326.4 | 30.49 |
Gain (Loss) on Sale of Assets | -0.09 | -0.01 | 0.67 | -0.5 | -6.43 | 0.01 |
Asset Writedown | -4.99 | -5.32 | -25.45 | -153.14 | -46.95 | -1.88 |
Other Unusual Items | -10.82 | -6.87 | -0.2 | 1.28 | -39.85 | 8.72 |
Pretax Income | 2,610 | 2,527 | 2,107 | 1,580 | 18,258 | 999.63 |
Income Tax Expense | 313.47 | 257.75 | 306.83 | 231.11 | 1,774 | 65.23 |
Earnings From Continuing Operations | 2,296 | 2,270 | 1,800 | 1,349 | 16,484 | 934.4 |
Minority Interest in Earnings | -2.15 | -2.76 | -131.31 | -97.62 | -453.93 | -25.76 |
Net Income | 2,294 | 2,267 | 1,669 | 1,252 | 16,030 | 908.64 |
Net Income to Common | 2,294 | 2,267 | 1,669 | 1,252 | 16,030 | 908.64 |
Net Income Growth | 35.93% | 35.84% | 33.33% | -92.19% | 1664.19% | 274.96% |
Shares Outstanding (Basic) | 428 | 433 | 438 | 445 | 456 | 455 |
Shares Outstanding (Diluted) | 429 | 435 | 441 | 452 | 467 | 455 |
Shares Change (YoY) | -2.33% | -1.38% | -2.49% | -3.23% | 2.82% | 5.02% |
EPS (Basic) | 5.36 | 5.23 | 3.81 | 2.81 | 35.14 | 2.00 |
EPS (Diluted) | 5.35 | 5.21 | 3.78 | 2.77 | 34.30 | 2.00 |
EPS Growth | 39.17% | 37.73% | 36.73% | -91.93% | 1615.80% | 257.03% |
Free Cash Flow | -581.12 | -431.13 | 912.83 | 1,557 | 18,010 | 222.67 |
Free Cash Flow Per Share | -1.35 | -0.99 | 2.07 | 3.44 | 38.53 | 0.49 |
Dividend Per Share | 1.650 | 1.650 | 0.200 | 0.300 | 2.500 | 0.700 |
Dividend Growth | 725.00% | 725.00% | -33.33% | -88.00% | 257.14% | 1066.67% |
Gross Margin | 59.74% | 61.67% | 69.72% | 60.54% | 78.99% | 63.09% |
Operating Margin | -30.58% | -23.75% | 26.12% | 23.29% | 70.30% | 38.35% |
Profit Margin | 197.75% | 165.99% | 64.38% | 38.74% | 60.92% | 37.91% |
Free Cash Flow Margin | -50.09% | -31.57% | 35.22% | 48.20% | 68.44% | 9.29% |
EBITDA | -334.43 | -297.33 | 730.86 | 829.08 | 18,574 | 985.28 |
EBITDA Margin | -28.83% | -21.77% | 28.19% | 25.66% | 70.58% | 41.10% |
D&A For EBITDA | 20.27 | 26.96 | 53.71 | 76.42 | 74.18 | 65.97 |
EBIT | -354.7 | -324.28 | 677.15 | 752.66 | 18,500 | 919.31 |
EBIT Margin | -30.58% | -23.75% | 26.12% | 23.29% | 70.30% | 38.35% |
Effective Tax Rate | 12.01% | 10.20% | 14.56% | 14.62% | 9.71% | 6.53% |
Revenue as Reported | 1,160 | 1,366 | 2,592 | 3,231 | 26,315 | 2,397 |
Advertising Expenses | - | 85.82 | 108.82 | 82.77 | 70.38 | 51.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.